Journey Medical (NASDAQ:DERM) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 31.03 percent. This is a 150 percent decrease over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $16.079 million which missed the analyst consensus estimate of $18.863 million by 14.76 percent. This is a 18.05 percent increase over sales of $13.620 million the same period last year.